As a local anesthetic, ropivacaine can reduce the activity of small GTPase by inhibiting the prenylation of small GTPase, which can inhibit the phosphorylation level of paxillin by inhibiting the MAPK/JNK signaling pathway, thereby reducing the migration of esophageal cancer cells [63]. This evidence concerns the gene PXN and esophageal cancer.